Proliferation of transplanted allogeneic pancreatic islets

Area of Science:

• Transplantation immunology
• Endocrinology
• Regenerative medicine

Background:

• Pancreatic islet regeneration is crucial for diabetes management.
• Allogeneic islet transplantation faces challenges with graft survival and rejection.
• Understanding islet cell proliferation and apoptosis is key to improving transplant outcomes.

Purpose of the Study:

• To investigate the proliferative potential of rat pancreatic islet cells within allogeneic grafts.
• To compare cell proliferation and apoptosis in accepted versus rejected islet transplants.
• To assess the role of a tolerance-inducing method in promoting islet graft survival.

Main Methods:

• Induction of diabetes using streptozotocin in Lewis rats.
• Allogeneic islet transplantation from WAG rats.
• Tolerance induction via UV-B irradiated bone marrow transplantation, splenocyte infusion, and cyclophosphamide.
• Assessment of islet cell proliferation using pKi-67 immunostaining.
• Evaluation of apoptosis using TUNEL assay and propidium iodide staining.

Main Results:

• Long-surviving allogeneic islet grafts exhibited significantly higher proliferation (5.61%) compared to normal pancreas (0.4%).
• Rejected grafts showed no significant increase in proliferation and exhibited significant endocrine cell apoptosis.
• Accepted grafts demonstrated a very low incidence of endocrine cell apoptosis.
• Histological examination confirmed the presence of functional beta and alpha cells in successful grafts.

Conclusions:

• The proliferation and apoptosis of endocrine cells differ significantly between accepted and rejected allogeneic islet grafts.
• Accepted islet allografts demonstrate enhanced regenerative capacity through increased cell proliferation.
• The findings support the potential for improved outcomes in islet transplantation by modulating cell proliferation and survival.